| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
250,429 |
232,853 |
$6.56M |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
46,324 |
44,877 |
$5.53M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
73,518 |
66,893 |
$3.14M |
| 88356 |
|
13,096 |
8,757 |
$1.83M |
| 95886 |
|
16,941 |
16,301 |
$1.33M |
| 99490 |
Ccm add 20min |
76,554 |
76,024 |
$1.30M |
| 88360 |
|
7,887 |
7,829 |
$1.21M |
| 64493 |
|
15,025 |
7,753 |
$978K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
8,852 |
8,772 |
$824K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
47,854 |
46,730 |
$819K |
| 95911 |
|
8,412 |
8,312 |
$742K |
| 88319 |
|
7,948 |
7,891 |
$717K |
| 64483 |
|
8,967 |
6,803 |
$610K |
| 64635 |
|
4,792 |
4,511 |
$540K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
4,698 |
4,483 |
$511K |
| 88314 |
|
8,819 |
8,741 |
$508K |
| 95913 |
|
3,553 |
3,500 |
$466K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
9,882 |
9,089 |
$465K |
| Q3014 |
Telehealth originating site facility fee |
19,289 |
18,434 |
$378K |
| 96138 |
|
24,608 |
23,379 |
$327K |
| 64494 |
|
14,045 |
7,460 |
$291K |
| 64636 |
|
4,716 |
4,435 |
$288K |
| 99205 |
Prolong outpt/office vis |
1,636 |
1,492 |
$262K |
| J3490 |
Unclassified drugs |
25,502 |
16,171 |
$262K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,965 |
5,744 |
$258K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
7,370 |
5,980 |
$235K |
| 64490 |
|
2,898 |
1,530 |
$230K |
| 11104 |
|
4,185 |
4,049 |
$227K |
| 64484 |
|
3,532 |
3,448 |
$187K |
| 20611 |
|
8,007 |
6,043 |
$176K |
| 99000 |
|
97,068 |
89,720 |
$156K |
| 11105 |
|
4,144 |
3,998 |
$132K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
10,835 |
8,380 |
$125K |
| 96103 |
|
11,284 |
10,403 |
$115K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,880 |
1,849 |
$112K |
| 64495 |
|
5,056 |
2,348 |
$111K |
| 76942 |
|
3,952 |
3,714 |
$107K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
952 |
843 |
$105K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
8,146 |
7,358 |
$67K |
| 95910 |
|
941 |
933 |
$67K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
7,287 |
6,953 |
$67K |
| 11100 |
|
2,622 |
2,490 |
$63K |
| 64491 |
|
2,639 |
1,416 |
$62K |
| 64633 |
|
392 |
366 |
$61K |
| 20553 |
|
1,347 |
1,281 |
$61K |
| 95912 |
|
489 |
473 |
$59K |
| 64479 |
|
643 |
487 |
$57K |
| T1014 |
Telehealth transmission, per minute, professional services bill separately |
18,245 |
17,422 |
$55K |
| 99152 |
|
10,651 |
10,123 |
$53K |
| 11101 |
|
2,572 |
2,449 |
$52K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,312 |
4,927 |
$51K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,174 |
4,889 |
$38K |
| 64634 |
|
381 |
355 |
$38K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
4,145 |
3,896 |
$37K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,170 |
840 |
$37K |
| 95924 |
|
529 |
528 |
$37K |
| 80306 |
|
1,272 |
1,199 |
$30K |
| 99406 |
|
8,848 |
7,970 |
$29K |
| 27096 |
|
119 |
72 |
$27K |
| 88341 |
|
575 |
553 |
$26K |
| 88342 |
|
575 |
553 |
$23K |
| 99442 |
|
1,380 |
1,338 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,183 |
1,161 |
$18K |
| 20526 |
|
462 |
282 |
$17K |
| 64492 |
|
695 |
307 |
$15K |
| 99487 |
Ccm add 20min |
102 |
102 |
$11K |
| 99443 |
|
650 |
595 |
$9K |
| 80305 |
|
1,027 |
1,005 |
$8K |
| 97026 |
|
3,161 |
2,372 |
$8K |
| 64480 |
|
80 |
79 |
$6K |
| 99243 |
|
173 |
168 |
$6K |
| 97813 |
|
4,212 |
3,179 |
$6K |
| 97814 |
|
4,207 |
3,176 |
$6K |
| 20552 |
|
152 |
123 |
$4K |
| 96127 |
|
2,604 |
2,600 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
322 |
317 |
$3K |
| 20610 |
|
46 |
31 |
$2K |
| 76882 |
|
78 |
78 |
$2K |
| J3300 |
Injection, triamcinolone acetonide, preservative free, 1 mg |
238 |
222 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
52 |
51 |
$915.96 |
| 95909 |
|
16 |
16 |
$904.33 |
| 90837 |
Psychotherapy, 53 minutes with patient |
78 |
71 |
$888.39 |
| 95923 |
|
298 |
294 |
$800.00 |
| J7321 |
Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
21 |
13 |
$768.34 |
| 99489 |
Ccm add 20min |
15 |
15 |
$759.90 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
35 |
35 |
$682.86 |
| 81025 |
|
357 |
354 |
$561.88 |
| 95908 |
|
52 |
52 |
$528.86 |
| 11721 |
|
47 |
47 |
$278.32 |
| 99407 |
|
14 |
14 |
$263.11 |
| 62323 |
|
33 |
32 |
$220.03 |
| 99441 |
|
66 |
65 |
$193.37 |
| 95957 |
|
25 |
25 |
$104.71 |
| 11720 |
|
14 |
14 |
$54.52 |
| 97124 |
|
2,631 |
1,995 |
$43.76 |
| 97016 |
|
2,169 |
1,667 |
$8.86 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
329 |
326 |
$0.00 |
| 97810 |
|
2,003 |
1,508 |
$0.00 |
| 76881 |
|
53 |
53 |
$0.00 |
| 63650 |
|
13 |
13 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
354 |
344 |
$0.00 |
| 92285 |
|
37 |
36 |
$0.00 |
| 3079F |
|
54 |
54 |
$0.00 |
| 3075F |
|
55 |
55 |
$0.00 |
| 92250 |
|
37 |
36 |
$0.00 |